News

Re-certification ISO13485:2016

November 08, 2021

Future Diagnostics proudly received the re-certification of ISO13485:2016 for the next 3 years. Zero non-conformities were found.

read post

COVID-19 measures at Future Diagnostics

July 05, 2021

We are committed to keeping you informed of our efforts throughout this pandemic, to make sure that our services to you are as un-affected as possible. The safety and well-being of our employees, their families and customers are our top priority.

read post

National Holidays in The Netherlands

April 01, 2021

Our company is closed during Easter, Dutch King’s Day, Ascension Day and Pentecost.

read post

Development of Photonic Biosensor Device

March 23, 2021

Together with the BioCDx consortium, Future Diagnostics has been proudly working on the development of a miniaturized, reliable biosensing system for accurate and highly sensitive detection of protein cancer biomarkers, for the treatment monitoring of cancer disease and the therapeutics response.

read post

New Vacancies

March 10, 2021

At Future Diagnostics, we work on tomorrow’s healthcare projects. That is what makes our work fun and interesting. Especially at this time when healthcare is being tested like this. We take COVID-19 and our responsibility as an employer seriously in this process, while recruiting new colleagues is also important to us. That is why you can also apply at Future Diagnostics during times of COVID-19.

read post

Happy Holiday Season

December 15, 2020

Last year was extraordinary. We would like to express our sincerest thanks for your continuous support. We cherish the safety and wellbeing of you, our colleagues, our clients and loved ones. We wish you a happy and healthy New Year and we hope to see you again in 2021.

read post

Future Diagnostics Enters Agreement with DIAsource Immunoassays for Free 25OH Vitamin D ELISA product

July 10, 2020

DIAsource Immunoassays (Louvain-la-Neuve, Belgium), a BioVendor group company, has entered into a strategic agreement with Future Diagnostics (Wijchen, The Netherlands) under which Future Diagnostics will transfer all assets, with the exclusion of IP, related to Free 25OH Vitamin D ELISA product to DIAsource, securing its continued production and sales.

read post

Update on SARS-CoV-2 from Future Diagnostics

April 03, 2020

We hope that everyone is remaining healthy during the SARS-CoV-2 outbreak. At Future Diagnostics, we work on tomorrow’s healthcare projects. That is what makes our work interesting. Especially at this time when healthcare is being challenged like this.

read post